Shore Capital Partners: Empowering Growth in the Industrial and Healthcare Sectors

Shore Capital Partners, a leading private equity firm, has recently closed two new funds, signaling its commitment to investing in the industrial and healthcare sectors. With over $640 million in capital raised, the firm continues to expand its portfolio and drive innovation in these industries. This milestone brings Shore's assets under management to over $6 billion, solidifying its position as a major player in the market. The success of these funds underscores Shore's ability to identify growth opportunities and deliver transformative results.

The first fund, Shore Capital Industrial Partners Fund I (IND Fund I), focuses on investing in microcap industrial companies. Led by Shore Founder and Managing Partner Justin Ishbia, along with Partners John Sznewajs and Dan Spradling, this fund will target aerospace and defense, building and facility services, transportation and logistics, environmental services, manufactured products/services, and industrial technology companies. With a revenue range of $5 million to $100 million, these investments have strong growth potential. IND Fund I surpassed its original target of $150 million, indicating strong investor interest in this sector.

Shore's entry into the industrial sector is strategic, as it recognizes the fragmented nature of the industry and the opportunities it presents. Leveraging its prior experience in similar businesses, the firm aims to accelerate growth and drive success in new industrial investments. By partnering with premier management teams and utilizing a top-down investment approach, Shore is poised to make a significant impact in this sector.

The second fund, Shore Capital Healthcare Partners Fund V (HC Fund V), is a testament to Shore's continued commitment to the healthcare industry. Led by Justin Ishbia, along with Shore Founding Partners John Hennegan, Ryan Kelley, and Mike Cooper, and Partners Don Pierce and Chris Mioton, HC Fund V targets microcap healthcare businesses. With a revenue range of $5 million to $200 million, these investments span various healthcare subsectors. The robustness of the healthcare industry, coupled with Shore's expertise and resources, positions HC Fund V for success.

Shore's investment strategy revolves around supporting microcap businesses in their growth journey. By providing access to capital, world-class boards and operational resources, and networking opportunities, Shore empowers these companies to grow faster with less risk. This approach has proven successful, as Shore has invested in 56 unique platform companies to date, with an additional 800-plus add-on acquisitions. The firm's portfolio spans approximately 1,500 locations and employs over 31,000 individuals. Shore's commitment to delivering value to its shareholders is evident in its track record of generating growth and innovation.

The success of the IND Fund I and HC Fund V is attributed to Shore's strong investor base, which includes existing investors as well as select new limited partners. This diverse group comprises university endowments, financial institutions, fund-of-funds, and family offices. The partners at Shore have also committed their own capital to these funds, further aligning their interests with those of their investors.

Kirkland & Ellis LLP served as the legal advisor for Shore during the fundraising efforts, highlighting the firm's commitment to excellence and ensuring a seamless process.

About Shore Capital Partners

Shore Capital Partners is a Chicago-based private equity firm that specializes in investing in microcap companies across various industries, including healthcare, food and beverage, business services, industrial, and real estate. With offices in Nashville, Shore takes a collaborative approach to support management partners in their growth initiatives. By providing access to capital, world-class boards and operational resources, and networking opportunities, Shore enables these companies to achieve accelerated growth with reduced risk. The firm's track record has been recognized by industry publications, with Inc. Magazine recognizing Shore as a top founder-friendly investor for three consecutive years. Additionally, Pitchbook research has named Shore as a leader in total deal volume among all U.S. private equity firms. With over $6 billion in assets under management and additional investment platforms, Shore continues to contribute to the success of its portfolio companies while providing business and operational services.

In conclusion, Shore Capital Partners' successful fundraising efforts for the IND Fund I and HC Fund V demonstrate its commitment to investing in the industrial and healthcare sectors. By leveraging its expertise and resources, Shore is well-positioned to empower growth in these industries and deliver transformative results. As the firm's assets under management continue to grow, Shore solidifies its position as a leading private equity firm dedicated to driving innovation and success in microcap businesses.